A new study has found an association between the use of restorative hearing devices and a reduced risk of developing dementia ...
Exact Sciences has been presenting new data from multiple trials supporting the role of its cancer screening and diagnostic ...
Takeda’s dengue vaccine candidate, Qdenga (TAK-003), has been approved by the European Commission (EC) for the prevention of ...
WHO also found patterns of increasing resistance to treatment in several bacteria-causing common infections in the community, ...
The Pfizer/ BioNTech vaccine is now indicated for children aged six months to four years who have not yet received the third ...
A trial of the NHS Digital Health Check, a new, first-of-its-kind check-up service, has been launched in Cornwall, England.
A health-centred, aligned response to the compounding crises can still deliver a future where people can not only survive, but thrive.’ It is now clear that devising corporate social responsibility ...
Pfizer’s Biologics License Application (BLA) for its its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or ...
Enzyvant Therapeutics (Enzyvant) and Altavant Sciences (Altavant) have announced a merger to form a biopharmaceutical company ...
Summit Therapeutics (Summit) has announced a definitive agreement of its partnership with Akeso in a deal worth up to $5bn to ...
Eli Lilly (Lilly) has shared its latest results from the pivotal phase 3 monarchE trial of Verzenio (abemaciclib) adjuvant in ...
If authorised, children in this age group would receive a primary series consisting of two 3µg doses of the original ...